Logo image of HLNE

HAMILTON LANE INC-CLASS A (HLNE) Stock Fundamental Analysis

USA - NASDAQ:HLNE - US4074971064 - Common Stock

118.85 USD
-0.95 (-0.79%)
Last: 10/9/2025, 4:25:02 PM
118.85 USD
0 (0%)
After Hours: 10/9/2025, 4:25:02 PM
Fundamental Rating

6

Overall HLNE gets a fundamental rating of 6 out of 10. We evaluated HLNE against 238 industry peers in the Capital Markets industry. HLNE has an excellent profitability rating, but there are some minor concerns on its financial health. HLNE is valued quite expensive, but it does show an excellent growth. These ratings could make HLNE a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

HLNE had positive earnings in the past year.
HLNE had a positive operating cash flow in the past year.
Each year in the past 5 years HLNE has been profitable.
HLNE had a positive operating cash flow in each of the past 5 years.
HLNE Yearly Net Income VS EBIT VS OCF VS FCFHLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

HLNE's Return On Assets of 11.78% is amongst the best of the industry. HLNE outperforms 92.02% of its industry peers.
HLNE has a better Return On Equity (27.96%) than 94.12% of its industry peers.
HLNE's Return On Invested Capital of 18.59% is amongst the best of the industry. HLNE outperforms 95.38% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HLNE is significantly above the industry average of 7.64%.
Industry RankSector Rank
ROA 11.78%
ROE 27.96%
ROIC 18.59%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
HLNE Yearly ROA, ROE, ROICHLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

1.3 Margins

The Profit Margin of HLNE (30.66%) is better than 76.05% of its industry peers.
In the last couple of years the Profit Margin of HLNE has grown nicely.
The Operating Margin of HLNE (43.91%) is better than 78.15% of its industry peers.
HLNE's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 43.91%
PM (TTM) 30.66%
GM N/A
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
HLNE Yearly Profit, Operating, Gross MarginsHLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

6

2. Health

2.1 Basic Checks

HLNE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HLNE has more shares outstanding
HLNE has a worse debt/assets ratio than last year.
HLNE Yearly Shares OutstandingHLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
HLNE Yearly Total Debt VS Total AssetsHLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

HLNE has an Altman-Z score of 5.20. This indicates that HLNE is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.20, HLNE belongs to the best of the industry, outperforming 86.13% of the companies in the same industry.
The Debt to FCF ratio of HLNE is 0.85, which is an excellent value as it means it would take HLNE, only 0.85 years of fcf income to pay off all of its debts.
HLNE has a Debt to FCF ratio of 0.85. This is amongst the best in the industry. HLNE outperforms 90.76% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that HLNE is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.38, HLNE is in the better half of the industry, outperforming 68.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 0.85
Altman-Z 5.2
ROIC/WACCN/A
WACCN/A
HLNE Yearly LT Debt VS Equity VS FCFHLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.16 indicates that HLNE should not have too much problems paying its short term obligations.
HLNE's Current ratio of 1.16 is in line compared to the rest of the industry. HLNE outperforms 53.78% of its industry peers.
A Quick Ratio of 1.16 indicates that HLNE should not have too much problems paying its short term obligations.
HLNE has a Quick ratio of 1.16. This is comparable to the rest of the industry: HLNE outperforms 54.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
HLNE Yearly Current Assets VS Current LiabilitesHLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

7

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.80% over the past year.
HLNE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.18% yearly.
The Revenue has grown by 10.65% in the past year. This is quite good.
The Revenue has been growing by 21.08% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)7.8%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%-13.25%
Revenue 1Y (TTM)10.65%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%-10.56%

3.2 Future

HLNE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.01% yearly.
HLNE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.52% yearly.
EPS Next Y-0.5%
EPS Next 2Y9.95%
EPS Next 3Y14.01%
EPS Next 5YN/A
Revenue Next Year7.46%
Revenue Next 2Y12.27%
Revenue Next 3Y14.52%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HLNE Yearly Revenue VS EstimatesHLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
HLNE Yearly EPS VS EstimatesHLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

HLNE is valuated rather expensively with a Price/Earnings ratio of 24.56.
Compared to the rest of the industry, the Price/Earnings ratio of HLNE indicates a slightly more expensive valuation: HLNE is more expensive than 65.13% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.70. HLNE is around the same levels.
HLNE is valuated rather expensively with a Price/Forward Earnings ratio of 19.51.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HLNE is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.15, HLNE is valued at the same level.
Industry RankSector Rank
PE 24.56
Fwd PE 19.51
HLNE Price Earnings VS Forward Price EarningsHLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

71.01% of the companies in the same industry are more expensive than HLNE, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLNE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 19.59
EV/EBITDA 21.21
HLNE Per share dataHLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

HLNE has a very decent profitability rating, which may justify a higher PE ratio.
HLNE's earnings are expected to grow with 14.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)1.22
EPS Next 2Y9.95%
EPS Next 3Y14.01%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.71%, HLNE has a reasonable but not impressive dividend return.
In the last 3 months the price of HLNE has falen by -21.49%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 8.50, HLNE is paying slightly less dividend.
HLNE's Dividend Yield is slightly below the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.71%

5.2 History

The dividend of HLNE is nicely growing with an annual growth rate of 19.56%!
HLNE has been paying a dividend for over 5 years, so it has already some track record.
As HLNE did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)19.56%
Div Incr Years7
Div Non Decr Years7
HLNE Yearly Dividends per shareHLNE Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

37.04% of the earnings are spent on dividend by HLNE. This is a low number and sustainable payout ratio.
HLNE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP37.04%
EPS Next 2Y9.95%
EPS Next 3Y14.01%
HLNE Yearly Income VS Free CF VS DividendHLNE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
HLNE Dividend Payout.HLNE Dividend Payout, showing the Payout Ratio.HLNE Dividend Payout.PayoutRetained Earnings

HAMILTON LANE INC-CLASS A

NASDAQ:HLNE (10/9/2025, 4:25:02 PM)

After market: 118.85 0 (0%)

118.85

-0.95 (-0.79%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners96.85%
Inst Owner Change0%
Ins Owners7.22%
Ins Owner Change-2.89%
Market Cap6.62B
Analysts50.91
Price Target168.71 (41.95%)
Short Float %6.23%
Short Ratio6.62
Dividend
Industry RankSector Rank
Dividend Yield 1.71%
Yearly Dividend1.38
Dividend Growth(5Y)19.56%
DP37.04%
Div Incr Years7
Div Non Decr Years7
Ex-Date09-19 2025-09-19 (0.54)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.26%
Min EPS beat(2)1.1%
Max EPS beat(2)27.41%
EPS beat(4)3
Avg EPS beat(4)9.11%
Min EPS beat(4)-3.63%
Max EPS beat(4)27.41%
EPS beat(8)5
Avg EPS beat(8)9.21%
EPS beat(12)8
Avg EPS beat(12)10.1%
EPS beat(16)12
Avg EPS beat(16)13.17%
Revenue beat(2)2
Avg Revenue beat(2)7.35%
Min Revenue beat(2)1.01%
Max Revenue beat(2)13.69%
Revenue beat(4)3
Avg Revenue beat(4)3.94%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)13.69%
Revenue beat(8)5
Avg Revenue beat(8)7.81%
Revenue beat(12)7
Avg Revenue beat(12)8.52%
Revenue beat(16)9
Avg Revenue beat(16)8.28%
PT rev (1m)1.6%
PT rev (3m)5.57%
EPS NQ rev (1m)-1.74%
EPS NQ rev (3m)4.09%
EPS NY rev (1m)0%
EPS NY rev (3m)8.3%
Revenue NQ rev (1m)-1.27%
Revenue NQ rev (3m)4.49%
Revenue NY rev (1m)-0.92%
Revenue NY rev (3m)5.13%
Valuation
Industry RankSector Rank
PE 24.56
Fwd PE 19.51
P/S 9.57
P/FCF 19.59
P/OCF 18.92
P/B 8.73
P/tB 8.73
EV/EBITDA 21.21
EPS(TTM)4.84
EY4.07%
EPS(NY)6.09
Fwd EY5.13%
FCF(TTM)6.07
FCFY5.1%
OCF(TTM)6.28
OCFY5.29%
SpS12.42
BVpS13.62
TBVpS13.62
PEG (NY)N/A
PEG (5Y)1.22
Profitability
Industry RankSector Rank
ROA 11.78%
ROE 27.96%
ROCE 22.22%
ROIC 18.59%
ROICexc 24.17%
ROICexgc 24.88%
OM 43.91%
PM (TTM) 30.66%
GM N/A
FCFM 48.83%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
ROICexc(3y)26.87%
ROICexc(5y)22.9%
ROICexgc(3y)28.19%
ROICexgc(5y)23.88%
ROCE(3y)26.99%
ROCE(5y)23.55%
ROICexcg growth 3Y19.01%
ROICexcg growth 5Y-5.25%
ROICexc growth 3Y19.07%
ROICexc growth 5Y-4.68%
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 0.85
Debt/EBITDA 0.92
Cap/Depr 126.25%
Cap/Sales 1.73%
Interest Coverage 250
Cash Conversion 111.67%
Profit Quality 159.29%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 5.2
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.9%
Cap/Depr(5y)192.46%
Cap/Sales(3y)1.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)135.75%
Profit Quality(5y)139.47%
High Growth Momentum
Growth
EPS 1Y (TTM)7.8%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%-13.25%
EPS Next Y-0.5%
EPS Next 2Y9.95%
EPS Next 3Y14.01%
EPS Next 5YN/A
Revenue 1Y (TTM)10.65%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%-10.56%
Revenue Next Year7.46%
Revenue Next 2Y12.27%
Revenue Next 3Y14.52%
Revenue Next 5YN/A
EBIT growth 1Y8.35%
EBIT growth 3Y23.2%
EBIT growth 5Y22.13%
EBIT Next Year7.75%
EBIT Next 3Y14%
EBIT Next 5YN/A
FCF growth 1Y55.62%
FCF growth 3Y21.48%
FCF growth 5Y21.24%
OCF growth 1Y56.53%
OCF growth 3Y21.07%
OCF growth 5Y20.91%